Class 2 Medicines recall: Desmopressin nasal spray – all strengths (Ferring Pharmaceuticals Limited)
Class 2 Medicines recall: Desmopressin nasal spray – all strengths (Ferring Pharmaceuticals Limited)
July 15, 2020
Class 2 MHRA medicines recall – Desmopressin nasal spray – all strengths (Ferring Pharmaceuticals Limited) – PL 03194/0024, PL 03194/0090, PL 03194/0056,
Drug alert number: EL (20)A/29
Date issued: 15 July 2020
The Medicines and Health products Regulatory Agency (MHRA) has issued a class 2 medicines recall for:
Desmopressin nasal spray – all strengths (Ferring Pharmaceuticals Limited) – PL 03194/0024, PL 03194/0090, PL 03194/0056,
Ferring Pharmaceuticals Limited is recalling all unexpired stock of the above batches of products from pharmacies and wholesalers as a precautionary measure due to a lower volume of solution being observed in the bottles, and out of specification results for the content of the desmopressin acetate (active substance) and benzalkonium chloride (excipient).
Desmospray® 0.1 mg/ml Nasal Spray – PL 03194/0024
| Batch Number | Expiry Date | Pack Size | First Distributed | |||
| P10427G | 28-02-21 | 1×1 | 26-06-18 | |||
| P11704A | 30-04-21 | 1×1 | 24-07-18 | |||
| P13215E | 31-05-21 | 1×1 | 26-09-18 | |||
| P13215K | 31-05-21 | 1×1 | 31-10-18 | |||
| P13215N | 31-05-21 | 1×1 | 04-12-18 | |||
| P15231G | 30-09-21 | 1×1 | 26-02-19 | |||
| P15231P | 30-09-21 | 1×1 | 16-04-19 | |||
| R11847E | 28-02-22 | 1×1 | 02-07-19 | |||
| R12217C | 30-04-22 | 1×1 | 03-09-19 | |||
| R13643H | 31-07-22 | 1×1 | 17-03-20 | |||
| R13643A | 31-07-22 | 1×1 | 07-10-19 | |||
| R17389K | 31-01-23 | 1×1 | 15-06-20 | |||
| R17389H | 31-01-23 | 1×1 | 27-04-20 | |||
| R13643S | 31-07-22 | 1×1 | 27-04-20 | |||
Desmopressin 0.1 mg/ml Nasal Spray – PL 03194/0090
Note: Products are packaged with Aspire livery
| Batch Number | Expiry Date | Pack Size | First Distributed |
| P10427L | 28-02-21 | 1×1 | 17-07-18 |
| P11704F | 30-04-21 | 1×1 | 17-07-18 |
| P15231T | 30-09-21 | 1×1 | 28-05-19 |
| R11847C | 28-02-22 | 1×1 | 17-07-19 |
| R13643F | 31-07-22 | 1×1 | 20-01-20 |
| R13643P | 31-07-22 | 1×1 | 20-04-20 |
| S11863A | 31-03-23 | 1×1 | 29-06-20 |
Octim® 1.5mg/ml Nasal Spray Solution – PL 03194/0056
| Batch Number | Expiry Date | Pack Size | First Distributed |
| N17445E | 31-12-20 | 1×1 | 04-04-18 |
| P13209F | 30-04-21 | 1×1 | 21-08-18 |
| P17637A | 31-12-21 | 1×1 | 09-04-19 |
| R13271G | 30-04-22 | 1×1 | 09-09-19 |
| R17378A | 31-12-22 | 1×1 | 27-04-20 |
Advice for healthcare professionals
Stop supplying the above batch immediately. Quarantine all remaining stock and return these to your supplier using your supplier’s approved process.
Further information
Full drug alert can be viewed here.
For more information or medical information queries, please contact:
Medical.UK@Ferring.com
0800 111 4126
For stock control queries, please contact
Customer.Services@Ferring.com
0800 111 4125
For Aspire livery stock (Desmopressin 0.1 mg/ml Nasal Spray, PL 03194/0090), please contact
customerservices@aspirepharma.co.uk
01730 231148
Posted in: Dispensing & Supply, PSNC News, Services & Commissioning
